The processing license will bring FSD's subsidiary FV Pharma Inc a step closer to securing a sales license
Inc () (OTCMKTS:FSDDF) announced Tuesday that its subsidiary FV Pharma Inc, a licensed Canadian cannabis producer, has received its standard processing license.
The license is required for any facility that is processing more than the equivalent of 600kg of dried flowers per year, per Health Canada’s new cannabis act regulations.
READ: FSD Pharma and Canntab Therapeutics forge pact with World Class Extractions to strike hemp deal
Dr Raza Bokhari, FSD’s interim CEO, said the processing license would bring its subsidiary closer to applying for a pre-sale inspection as well as a sales license.
“Receiving the processing license allows the company to begin packaging cannabis for inspection by Health Canada,” said Bokhari, in a statement. “With the pre-sale inspection just around the corner, we anticipate receiving our sales license and begin generating a revenue stream.”
Based in Toronto, focuses on the development of indoor grown, pharmaceutical-grade cannabis and the development of cannabinoid-based treatments for central nervous system disorders such as chronic pain and irritable bowel syndrome.
Contact Ellen Kelleher at [email protected]
CSE:HUGE
Market: CSE
Market Cap: $63.39 m
Follow
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of FSD Pharma named herein, including the promotion by the Company of FSD Pharma in any Content on the Site, the Company receives from said issuer...
FOR OUR FULL DISCLAIMER CLICK HEREMost read
FSD Pharma rings the Nasdaq opening bell in 'exciting and momentous moment'
FSD Pharma Inc (NASDAQ:HUGE) (CSE:HUGE) CEO Raza Bokhari, who runs the pharmaceutical cannabis research company, rang the Nasdaq opening bell together with with members of the board, leadership team, early investors, and others. Bokhari says it was an 'exciting and momentous moment' for the...
1 week, 2 days ago
2 min read
Prev article
2 min read
